Lin L H, Chen L L, Zirrolli J A, Harris R A
Department of Pharmacology, University of Colorado Health Sciences Center, Denver, Colorado.
J Pharmacol Exp Ther. 1992 Nov;263(2):569-78.
Potentiation of the gamma-aminobutyric acid (GABAA) receptor-gated Cl- channel response has been suggested to be a primary action of some anesthetic agents. We asked whether the GABAA receptor is a target site common for general anesthetics that are chemically and structurally diverse. This hypothesis was tested in Xenopus oocytes expressing mouse cortical mRNA, and GABA-activated Cl- currents were measured using two-electrode voltage clamping. General anesthetics, including inhalational (halothane, diethylether, enflurane and isoflurane), i.v. (3 alpha-hydroxy-5 alpha-dihydroprogesterone, ketamine and propofol) and alcohol (pentanol) anesthetics, enhanced GABA-induced currents by 56 to 1089% at concentrations that were clinically relevant. The results suggest that potentiation of the GABAA receptor/channel response may be a common action for anesthetic agents. Moreover, anesthetic effects were dependent on GABA concentrations; the enhancement was marked with low GABA concentrations and was exponentially decreased as the GABA concentration increased. Also, anesthetic effects were dependent on anesthetic concentrations. The apparent EC50 of halothane was found to be similar to the anesthetic ED50. We also investigated the role of intracellular Ca++ in mediating anesthetic enhancement of the GABA current. We found that intracellular injection of the Ca++ chelator, EGTA, did not change the enhancement by anesthetics. In addition, these anesthetics alone did not produce significant currents, suggesting that the Ca(++)-dependent Cl- current was not activated by these anesthetics per se. Thus, we found that diverse anesthetics potentiate GABA-induced Cl- currents, but this action is not mediated by a release of intracellular Ca++.
γ-氨基丁酸(GABAA)受体门控性氯离子通道反应的增强被认为是某些麻醉剂的主要作用。我们探讨了GABAA受体是否是化学结构各异的全身麻醉药的共同靶点。该假设在表达小鼠皮质mRNA的非洲爪蟾卵母细胞中进行了验证,采用双电极电压钳技术测量GABA激活的氯离子电流。全身麻醉药,包括吸入性麻醉药(氟烷、乙醚、恩氟烷和异氟烷)、静脉麻醉药(3α-羟基-5α-二氢孕酮、氯胺酮和丙泊酚)以及酒精(戊醇)麻醉药,在临床相关浓度下可使GABA诱导的电流增强56%至1089%。结果表明,增强GABAA受体/通道反应可能是麻醉药的共同作用。此外,麻醉效果取决于GABA浓度;低GABA浓度时增强作用明显,且随着GABA浓度增加呈指数下降。同时,麻醉效果也取决于麻醉药浓度。发现氟烷的表观半数有效浓度(EC50)与麻醉半数有效剂量(ED50)相似。我们还研究了细胞内钙离子在介导麻醉药增强GABA电流中的作用。我们发现向细胞内注射钙离子螯合剂乙二醇双四乙酸(EGTA)并不会改变麻醉药的增强作用。此外,这些麻醉药单独使用时不会产生明显电流,这表明这些麻醉药本身不会激活钙离子依赖性氯离子电流。因此,我们发现多种麻醉药可增强GABA诱导的氯离子电流,但该作用并非由细胞内钙离子释放介导。